Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings from New York City, 13 May to 21 July 2020
Public Domain
-
2021/07/15
-
Details
-
Personal Author:Cornell J ; Crawley A ; Daskalakis D ; Li J ; Maldin B ; Marovich S ; Pathela P ; Purdin J ; Schumacher PK ; Weiss D
-
Description:Background: New York City (NYC) was the US epicenter of the spring 2020 coronavirus disease 2019 (COVID-19) pandemic. We present the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and correlates of seropositivity immediately after the first wave. Methods: From a serosurvey of adult NYC residents (13 May to 21 July 2020), we calculated the prevalence of SARS-CoV-2 antibodies stratified by participant demographics, symptom history, health status, and employment industry. We used multivariable regression models to assess associations between participant characteristics and seropositivity. Results: The seroprevalence among 45 367 participants was 23.6% (95% confidence interval, 23.2%-24.0%). High seroprevalence (>30%) was observed among black and Hispanic individuals, people from high poverty neighborhoods, and people in healthcare or essential worker industry sectors. COVID-19 symptom history was associated with seropositivity (adjusted relative risk, 2.76; 95% confidence interval, 2.65-2.88). Other risk factors included sex, age, race/ethnicity, residential area, employment sector, working outside the home, contact with a COVID-19 case, obesity, and increasing numbers of household members. Conclusions: Based on a large serosurvey in a single US jurisdiction, we estimate that just under one-quarter of NYC adults were infected in the first few months of the COVID-19 epidemic. Given disparities in infection risk, effective interventions for at-risk groups are needed during ongoing transmission. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0022-1899
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:196-206
-
Volume:224
-
Issue:2
-
NIOSHTIC Number:nn:20063135
-
Citation:J Infect Dis 2021 Jul; 224(2):196-206
-
Contact Point Address:Preeti Pathela, DrPH, MPH, New York City Department of Health and Mental Hygiene, Gotham Center, 42-09 28th Street, Queens, New York 11101-4132
-
Email:ppathela@health.nyc.gov
-
Federal Fiscal Year:2021
-
Peer Reviewed:True
-
Source Full Name:The Journal of Infectious Diseases
-
Collection(s):
-
Main Document Checksum:urn:sha-512:122143b1bca517b73b18dfc43791eb9f4a2fbd8fe6b4b2948c68116300a9725bb76777bffc63c4e7baeef81f1c65a6d23f31e3b80373aeb02769b966afe6b940
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like